http://www.mirati.com
Mirati Therapeutics, Inc. Company Intro
Mirati is developing a pipeline of novel therapeutics that has the potential to improve the lives of patients, by directly targeting genetic and immunological drivers of cancer.
Industry
Healthcare
Mirati Therapeutics, Inc. Headquaters
9393 Towne Centre Drive
San Diego,92121
United States
Mirati Therapeutics, Inc. Share price
14 Sep 2022 09:47 GMT
$83.38
-3.22 (-3.72 %)
Mirati Therapeutics, Inc. Market cap
$4.586 B
WMC RANKING
2022
Mirati Therapeutics, Inc. # 221
BiotechnologyLatest Mirati Therapeutics, Inc. News
29 Nov 2022
Mirati Therapeutics, Inc. (NASDAQ:MRTX) Insider Charles M ...
Mirati Therapeutics, Inc, a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the...
29 Nov 2022
Regulus Therapeutics Announces Appointments of Industry ...
Previously she held similar roles at Mirati Therapeutics, ... Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the...
29 Nov 2022
Is Mirati Therapeutics Inc. (NASDAQ: MRTX) Still Trending?
Mirati Therapeutics Inc. (NASDAQ:MRTX) price closed lower on Monday, November 28, dropping -2.99% below its previous close.
WMC Market Score
WMC Market to Revenue Score
Mirati Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Mirati Therapeutics, Inc. | USD | $13,131 | $425,428 | $-407,092 | $45,860B | 221 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mirati Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Mirati Therapeutics, Inc. Post vs Top 4 Industry Competitors
Mirati Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Mirati Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Mirati Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Mirati Therapeutics, Inc. | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
